semaglutide connective tissue The Therapeutic Effects of in Congenital Linear Scleroderma Semaglutide | GLP-1R Agonist |

Similar promise has been observed for Parkinsons and Huntingtons diseases, as GLP-1s have shown promise in animal studies, improving motor function, preserving dopaminergic neurons, and reducing oxidative stress.[142] Their ability to enhance glucose metabolism and reduce insulin resistancemechanisms believed to be implicated in the progression of neurodegenerationadds further rationale for exploration in these conditions

Weight Loss Efficacy: What the Trials Show The most reliable data comes from the manufacturers pivotal trials, which are large, randomized, placebo-controlled and FDA-reviewed

This recommendation should be individualized, particularly for patients with kidney disease

This is the same mechanism behind the initial rapid weight loss seen in low-carb diets